Abstract
Astrocytes in the central nervous system have physiologically important roles in the response to brain injury 1, 2 . Brain damage results in disruption of the blood–brain barrier (BBB), producing detachment of astrocyte endfeet from endothelial cells 3 . The resultant leakage of serum proteins from loosened tight junctions between endothelial cells produces brain edema. At the same time, reactive astrocytes migrate to the injured area, where they proliferate and produce extracellular matrix 4, 5, 6 , thereby reconstituting the BBB. As astrocytes are known to express angiotensinogen 7, 8 , which is the precursor of angiotensins (AI to AIV), we have investigated a possible functional contribution of angiotensinogen or one of its metabolites to BBB reconstitution. The astrocytes of angiotensinogen knockout mice had very attenuated expression of glial fibrially acidic protein and decreased laminin production in response to cold injury, and ultimately incomplete reconstitution of impaired BBB function. Although these abnormalities were rescued by administration of AII or AIV, the restoration of BBB function was not inhibited by AII type 1 and 2 receptor antagonists. These findings provide evidence that astrocytes with angiotensins are required for functional maintenance of the BBB.
Access options
Subscribe to Journal
Get full journal access for 1 year
$209.00
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.




References
- 1
Nieto-Sampedro, M., Saneto, R.P., De Vellis, J. & Cotman, C.W. The control of glial populations in brain: Changes in astrocyte mitogenic and morphogenic factors in response to injury. Brain Res. 343, 320–328 (1985).
- 2
Norenberg, M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53, 213–220 ( 1994).
- 3
Janzer, R.C. & Raff, M.C. Astrocytes induce blood–brain barrier properties in endothelial cells. Nature 325 , 253–257 (1987).
- 4
Ludwin, SK. Reaction of oligodendrocytes and astrocytes to trauma and implantation. Lab. Invest. 53, 20 –30 (1985).
- 5
Laywell, E.D. et al. Enhanced expression of the developmentally regulated extracellular matrix molecule tenasin following adult brain injury. Proc. Natl. Acad. Sci. USA 89, 2634–2638 (1992).
- 6
Reier, P.J. in Cell Biology and Pathology of Astrocytes (ed. Waxman, S.G.) 263 –324 (Academic, Orlando, Florida 1986 ).
- 7
Stornetta, R.L., Hawelu-Johnson, C.L., Guyenet, P.G. & Lynch, K.R. Astrocytes synthesize angiotensinogen in brain. Science 242, 1444–1446 (1988).
- 8
Milsted, A., Barna, B.P., Ransohof, R.M., Brosnihan, K.B. & Ferrario, C.M. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc. Natl. Acad. Sci. USA 87, 5720–5723 ( 1990).
- 9
Tanimoto, K. et al. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269, 31334–31337 (1994).
- 10
Sugiyama, F. et al. Speedy backcrossing through in vitro fertilization, using pre-pubertal superovulation and neonatal death dependent on genetic background in angiotensinogen-deficient mice. Lab. Anim. Sci. 47, 545–548 (1997).
- 11
Chan, P.H., Longar, S. & Fishman, R.A. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann. Neurol. 21, 540–547 (1987).
- 12
Hama, H. et al. Role of endothelin-1 in astrocyte responses after acute brain damage. J. Neurosci. Res. 47, 590– 602 (1997).
- 13
Liedtke, W. et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17 , 607–615 (1996).
- 14
Goldstein, G.W. & Betz, A.L. The blood–brain barrier. Sci. Am. 255, 70– 83 (1986).
- 15
Le-Prince, G., Fages, C., Rolaand, B., Nunez, J. & Tardy, M. DBcAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary culture. Glia 4, 322–326 (1991).
- 16
Eng, L.F. & Ghirnikar, R.S. GFAP and astrogliosis. Brain Pathol. 4, 229–237 (1994).
- 17
Wright, J.W. et al. The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16, 23–52 (1995).
- 18
Roberts, K.A. et al. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res. 682, 13–21 (1995).
- 19
Miller-Wing, A.V., et al. Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J. Pharmacol. Exp. Ther. 266, 1718–1726 (1993).
- 20
Moeller, I. et al. Distribution of AT4 receptors in the Macaca fascicularis brain. Brain Res. 712, 307– 324 (1996).
- 21
De Oliveira, A.M., Viswanathan, M., Heemskerk, F.M.J. & Saavedra, J.M. Expression of a novel angiotensin II receptor subtype in gerbil brain. Brain Res. 705, 177–187 (1995).
- 22
Shibouta, Y. et al. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug (+/-)-1- (cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). J. Pharmacol. Exp. Ther. 266, 114–120 (1993).
- 23
Dudley, D.T. et al. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38, 370– 377 (1990).
- 24
Wright, J.W., Bechtholt, A.J., Chambers, S.L. & Harding, J.W. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides 17, 1365– 1371 (1996).
- 25
Warnick, R.E. et al. Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity. J. Neurosci. Methods 58, 167–171 ( 1995).
Acknowledgements
This work was supported by grants from the 'Research for the Future' Program (The Japan Society for the Promotion of Science: JSPS―RFTF 97L00804), the Ministry of Education, Science, Sports, and Culture, The Mitsubishi Foundation, Uehara Memorial Foundation, Kanae Foundation of Research for New Medicine, The Inamori Foundation, The Asahi Glass Foundation, The Naito Foundation, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and The Nissan Science Foundation. We acknowledge our laboratory members for discussions and encouragement.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kakinuma, Y., Hama, H., Sugiyama, F. et al. Impaired blood–brain barrier function in angiotensinogen-deficient mice. Nat Med 4, 1078–1080 (1998). https://doi.org/10.1038/2070
Received:
Accepted:
Issue Date:
Further reading
-
Characteristic Effects of the Cardiac Non-Neuronal Acetylcholine System Augmentation on Brain Functions
International Journal of Molecular Sciences (2021)
-
Astrocytes are necessary for blood–brain barrier maintenance in the adult mouse brain
Glia (2021)
-
Chronic Treatment With Hydrogen Sulfide Donor GYY4137 Mitigates Microglial and Astrocyte Activation in the Spinal Cord of Streptozotocin-Induced Diabetic Rats
Journal of Neuropathology & Experimental Neurology (2020)
-
Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders
Pharmacological Research (2020)
-
Potentiating a non-neuronal cardiac cholinergic system reinforces the functional integrity of the blood brain barrier associated with systemic anti-inflammatory responses
Brain, Behavior, and Immunity (2019)